Summary
Procter & Gamble (PG) reported strong results for the six months ended December 31, 2020, with net sales increasing by 8% to $39.1 billion and net earnings rising by 11% to $8.2 billion. This growth was driven by broad-based strength across its segments, particularly Fabric & Home Care and Health Care, which saw double-digit increases. The company highlighted a 9% increase in organic sales, underscoring its ability to grow underlying business performance. Diluted EPS saw a substantial 12% increase to $3.10, reflecting improved profitability. The company also demonstrated robust cash flow generation, with operating cash flow of $10.2 billion and adjusted free cash flow of $9.0 billion, resulting in an impressive adjusted free cash flow productivity of 104%. This strong financial performance enabled significant returns to shareholders, with $5.0 billion used for treasury stock purchases and $4.1 billion distributed as dividends during the period. The company's focus on productivity and cost savings, alongside favorable market demand for its essential products amplified by the COVID-19 pandemic, contributed to these positive results.
Financial Highlights
53 data points| Revenue | $19.75B |
| Cost of Revenue | $9.25B |
| Gross Profit | $10.49B |
| SG&A Expenses | $5.11B |
| Operating Income | $5.38B |
| Interest Expense | $143.00M |
| Net Income | $3.85B |
| EPS (Basic) | $1.53 |
| EPS (Diluted) | $1.47 |
| Shares Outstanding (Basic) | 2.48B |
| Shares Outstanding (Diluted) | 2.62B |
Key Highlights
- 1Net sales increased 8% year-over-year to $39.1 billion for the six months ended December 31, 2020, driven by strong performance across key segments.
- 2Organic sales grew 9%, indicating robust underlying business growth excluding currency fluctuations and divestitures.
- 3Net earnings rose 11% to $8.2 billion, with diluted EPS increasing 12% to $3.10.
- 4Fabric & Home Care and Health Care segments showed particularly strong performance with double-digit sales increases.
- 5Operating cash flow was $10.2 billion, and adjusted free cash flow was $9.0 billion, with high productivity of 104%.
- 6The company returned $9.1 billion to shareholders through dividends and share repurchases during the period.
- 7The COVID-19 pandemic positively impacted demand for certain product categories, contributing to sales growth, although some regions and product lines experienced declines.